Results 151 to 160 of about 1,473,739 (314)

How do the incomes of Israeli Arab physicians compare with those of Israeli Jewish physicians? [PDF]

Isr J Health Policy Res
Rosen B, Miaari S.
europepmc   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

An Algorithm at the Table at Multidisciplinary Diagnostic Meetings: A Dramaturgical Analysis. [PDF]

Sociol Health Illn
Dingelstad J, Grommé F, Hoeven CT, Wallenburg I.   +3 more
europepmc   +1 more source

Maimonides as a Physician [PDF]

Gesnerus, 1982
openaire   +3 more sources

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Buprenorphine prescribing is increasingly delivered by primary care nurse practitioners to Medicaid beneficiaries. [PDF]

J Am Assoc Nurse Pract
Turi E, Lorenc E, Fadeyibi O, Johnson J, Ryhal C, Lim S, Williams S, Shen L, Compton P, Candon M.   +9 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Multidimensional advice networks in primary health care. [PDF]

Prim Health Care Res Dev
Aydin Teker I, Mansur F.
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

POS-461 A LUPUS NEPHROLOGIST'S NIGHTMARE- MANAGEMENT OF A YOUNG PATIENT WITH SEVERE COMBINED CLASS IV AND V LUPUS NEPHRITIS,STEROID INTOLERANCE AND COMCOMITANT HEPATITIS B VIRAL LOAD

Kidney International Reports, 2021
E. Okundaye, C. Ogbonnaya- Odor, T. Omitogun, A. Osborn   +3 more
doaj   +1 more source